• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不对称1,5-二芳基戊-1,4-二烯-3-酮:前列腺上皮细胞模型中的抗增殖活性及药代动力学研究

Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.

作者信息

Zhang Xiaojie, Guo Shanchun, Chen Chengsheng, Perez German Ruiz, Zhang Changde, Patanapongpibul Manee, Subrahmanyam Nithya, Wang Rubing, Keith Joshua, Chen Guanglin, Dong Yan, Zhang Qiang, Zhong Qiu, Zheng Shilong, Wang Guangdi, Chen Qiao-Hong

机构信息

Department of Chemistry, California State University, Fresno, 2555 E. San Ramon Avenue, M/S SB70, Fresno, CA 93740, USA.

Department of Chemistry, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA; RCMI Cancer Research Center, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA.

出版信息

Eur J Med Chem. 2017 Sep 8;137:263-279. doi: 10.1016/j.ejmech.2017.05.062. Epub 2017 Jun 3.

DOI:10.1016/j.ejmech.2017.05.062
PMID:28601720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5548007/
Abstract

To further engineer dienones with optimal combinations of potency and bioavailability, thirty-four asymmetric 1,5-diarylpenta-1,4-dien-3-ones (25-58) have been designed and synthesized for the evaluation of their in vitro anti-proliferative activity in three human prostate cancer cell lines and one non-neoplastic prostate epithelial cell line. All these asymmetric dienones are sufficiently more potent than curcumin and their corresponding symmetric counterparts. The optimal dienone 58, with IC values in the range of 0.03-0.12 μM, is 636-, 219-, and 454-fold more potent than curcumin in three prostate cancer cell models. Dienones 28 and 49 emerged as the most promising asymmetric dienones that warrant further preclinical studies. The two lead compounds demonstrated substantially improved potency in cell models and superior bioavailability in rats, while exhibiting no acute toxicity in the animals at the dose of 10 mg/kg. Dienones 28 and 46 can induce PC-3 cell cycle regulation at the G/G phase. However, dienone 28 induces PC-3 cell death in a different way from 46 even though they share the same scaffold, indicating that terminal heteroaromatic rings are critical to the action of mechanism for each specific dienone.

摘要

为了进一步构建具有最佳效力和生物利用度组合的二烯酮,设计并合成了34种不对称的1,5 - 二芳基戊 - 1,4 - 二烯 - 3 - 酮(25 - 58),以评估它们在三种人前列腺癌细胞系和一种非肿瘤性前列腺上皮细胞系中的体外抗增殖活性。所有这些不对称二烯酮的效力均比姜黄素及其相应的对称类似物强得多。最佳二烯酮58的IC值在0.03 - 0.12 μM范围内,在三种前列腺癌细胞模型中比姜黄素的效力分别高636倍、219倍和454倍。二烯酮28和49成为最有前景的不对称二烯酮,值得进一步进行临床前研究。这两种先导化合物在细胞模型中表现出显著提高的效力,在大鼠中具有优异的生物利用度,同时在10 mg/kg剂量下对动物无急性毒性。二烯酮28和46可在G/G期诱导PC - 3细胞周期调控。然而,尽管二烯酮28和46具有相同的骨架,但它们诱导PC - 3细胞死亡的方式不同,这表明末端杂芳环对于每种特定二烯酮的作用机制至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/f58219bf0fd0/nihms883599f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/649114abd394/nihms883599f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/0bc09e7b0dd7/nihms883599f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/d30d47b22883/nihms883599f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/4c1d4564477d/nihms883599f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/f78c4f099d1e/nihms883599f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/5bc6b710d4e1/nihms883599f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/f58219bf0fd0/nihms883599f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/649114abd394/nihms883599f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/0bc09e7b0dd7/nihms883599f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/d30d47b22883/nihms883599f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/4c1d4564477d/nihms883599f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/f78c4f099d1e/nihms883599f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/5bc6b710d4e1/nihms883599f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d88a/5548007/f58219bf0fd0/nihms883599f7.jpg

相似文献

1
Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.不对称1,5-二芳基戊-1,4-二烯-3-酮:前列腺上皮细胞模型中的抗增殖活性及药代动力学研究
Eur J Med Chem. 2017 Sep 8;137:263-279. doi: 10.1016/j.ejmech.2017.05.062. Epub 2017 Jun 3.
2
Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.二芳基戊二烯酮类化合物作为治疗前列腺癌化疗药物的优化。
Bioorg Med Chem. 2018 Sep 1;26(16):4751-4760. doi: 10.1016/j.bmc.2018.08.018. Epub 2018 Aug 13.
3
Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.在前列腺上皮细胞模型中对具有两个不同末端环的1,7 - 二杂芳基庚 - 1,4,6 - 三烯 - 3 - 酮进行构效关系研究。
Eur J Med Chem. 2017 Jun 16;133:208-226. doi: 10.1016/j.ejmech.2017.03.067. Epub 2017 Mar 29.
4
Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.基于姜黄素的抗癌剂1,7-二杂芳基庚-1,4,6-三烯-3-酮的合成与评价
Eur J Med Chem. 2016 Mar 3;110:164-80. doi: 10.1016/j.ejmech.2016.01.017. Epub 2016 Jan 21.
5
Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.1,5-二杂芳基戊-1,4-二烯-3-酮类化合物的构效关系及药代动力学研究:一类有前景的基于姜黄素的抗癌剂
J Med Chem. 2015 Jun 11;58(11):4713-26. doi: 10.1021/acs.jmedchem.5b00470. Epub 2015 May 22.
6
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.3-O-取代黄酮醇类化合物作为抗前列腺癌药物的构效关系和药代动力学研究。
Eur J Med Chem. 2018 Sep 5;157:978-993. doi: 10.1016/j.ejmech.2018.08.047. Epub 2018 Aug 22.
7
Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.新型抗前列腺癌药物1,9 - 二杂芳基壬 - 1,3,6,8 - 四烯 - 5 - 酮的设计、合成及生物学评价
Bioorg Med Chem. 2016 Oct 1;24(19):4692-4700. doi: 10.1016/j.bmc.2016.08.006. Epub 2016 Aug 6.
8
Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.水飞蓟宾衍生物作为抗前列腺癌药物:合成与细胞水平评价
Eur J Med Chem. 2016 Feb 15;109:36-46. doi: 10.1016/j.ejmech.2015.12.041. Epub 2015 Dec 24.
9
Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.新型恶二唑衍生物作为潜在前列腺癌药物的设计与评估
Bioorg Med Chem Lett. 2016 Jun 15;26(12):2847-2851. doi: 10.1016/j.bmcl.2016.04.058. Epub 2016 Apr 21.
10
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.3 - O - 取代的3',4',5' - 三甲氧基黄酮醇:作为抗前列腺癌药物的合成及基于细胞的评价
Bioorg Med Chem. 2017 Sep 1;25(17):4768-4777. doi: 10.1016/j.bmc.2017.07.022. Epub 2017 Jul 21.

引用本文的文献

1
Effects of curcumin and ursolic acid in prostate cancer: A systematic review.姜黄素和熊果酸对前列腺癌的影响:系统评价。
Urologia. 2024 Feb;91(1):90-106. doi: 10.1177/03915603231202304. Epub 2023 Sep 30.
2
1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel.1-色烯基-5-咪唑戊二烯酮对三阴性乳腺癌具有抗癌作用,并与紫杉醇具有协同作用。
Int J Mol Sci. 2020 Aug 12;21(16):5777. doi: 10.3390/ijms21165777.

本文引用的文献

1
Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.新型抗前列腺癌药物1,9 - 二杂芳基壬 - 1,3,6,8 - 四烯 - 5 - 酮的设计、合成及生物学评价
Bioorg Med Chem. 2016 Oct 1;24(19):4692-4700. doi: 10.1016/j.bmc.2016.08.006. Epub 2016 Aug 6.
2
Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines.不对称单羰基姜黄素类似物的合成及其对脂多糖诱导的小鼠和人巨噬细胞系中前列腺素E2生成的强效抑制作用。
Bioorg Med Chem Lett. 2016 May 15;26(10):2531-2538. doi: 10.1016/j.bmcl.2016.03.092. Epub 2016 Mar 26.
3
Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
基于姜黄素的抗癌剂1,7-二杂芳基庚-1,4,6-三烯-3-酮的合成与评价
Eur J Med Chem. 2016 Mar 3;110:164-80. doi: 10.1016/j.ejmech.2016.01.017. Epub 2016 Jan 21.
4
Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.1,5-二杂芳基戊-1,4-二烯-3-酮类化合物的构效关系及药代动力学研究:一类有前景的基于姜黄素的抗癌剂
J Med Chem. 2015 Jun 11;58(11):4713-26. doi: 10.1021/acs.jmedchem.5b00470. Epub 2015 May 22.
5
Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.不对称姜黄素类似物的抗氧化和抗肿瘤特性的合成与评估
Eur J Med Chem. 2015 Mar 26;93:461-9. doi: 10.1016/j.ejmech.2015.02.005. Epub 2015 Feb 7.
6
Curcumin-based anti-prostate cancer agents.基于姜黄素的抗前列腺癌药物。
Anticancer Agents Med Chem. 2015;15(2):138-56. doi: 10.2174/1871520615666150116102442.
7
Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).消除姜黄素分子中的心脏:单羰基姜黄素模拟物 (MACs)。
Molecules. 2014 Dec 24;20(1):249-92. doi: 10.3390/molecules20010249.
8
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.雄激素受体剪接变体在介导对雄激素靶向治疗的耐药性中激活全长受体。
Oncotarget. 2014 Mar 30;5(6):1646-56. doi: 10.18632/oncotarget.1802.
9
Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.姜黄素新型杂芳族类似物作为抗癌剂的设计、合成与评估。
Eur J Med Chem. 2014 Mar 21;75:123-31. doi: 10.1016/j.ejmech.2014.01.041. Epub 2014 Jan 29.
10
Mechanisms of the androgen receptor splicing in prostate cancer cells.雄激素受体剪接在前列腺癌细胞中的机制。
Oncogene. 2014 Jun 12;33(24):3140-50. doi: 10.1038/onc.2013.284. Epub 2013 Jul 15.